Speaker illustration

Professor Jan Eriksson

Uppsala University, Uppsala (Sweden)

Present position: MD, PhD, Full Professor and Chair in Clinical Diabetes and Metabolism, Dept of Medical Sciences and Senior consultant at Uppsala University and University Hospital, Endocrinology and Diabetes. Board-certified specialist in Internal Medicine and Endocrinology. Previously senior consultant physician at University Hospitals in Gothenburg and Umeå. Currently, leader of research group (25 members) in experimental and clinical diabetology, obesity and metabolism. Author of more than 250 papers in international scientific journals. Supervision of about 25 PhD and 15 post-doc fellows. Translational research on disease mechanisms and novel interventions in diabetes, obesity and their complications. During 2003-2013 full-time senior leadership positions at AstraZeneca, Global R&D, Early Clinical Development. Executive Medical Science Director for Diabetes & Obesity. Leader of several multidisciplinary research consortia involving academia, health care and industry.

SGLT2 inhibitors for obesity

Event: ESC Congress 2024

Topic: Antidiabetic Pharmacotherapy

Session: When the diet does not work: pharmacological options for obesity

Thumbnail